[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100584947":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":34,"responsibleParty":52,"collaborators":20,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":20,"enrollmentInfo":64,"targetDuration":20,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":76,"overallStatus":37,"whyStopped":20,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"University of Chile","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients with periodontitis and Diabetes Mellitus type 2","EXPERIMENTAL","There will be a group of patients to intervene, who present periodontitis and Diabetes Mellitus type 2.",[13],"Procedure: Non-surgical periodontal treatment, glycated hemoglobin measurement and application of OHIP-14SP survey.",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"PROCEDURE","Non-surgical periodontal treatment, glycated hemoglobin measurement and application of OHIP-14SP survey.","Non-surgical periodontal treatment will be performed, with periodontal maintenance therapy at 3, 6, 9 and 12 months, with measurement of glycated hemoglobin at each time and application of the OHIP-14SP oral health-related quality of life survey.",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Melisa Vera, Specialist in periodontics","PRINCIPAL_INVESTIGATOR",[26,31],{"name":23,"role":27,"phone":28,"phoneExt":29,"email":30},"CONTACT","+56976442451","+569","mvera@odontologia.uchile.cl",{"name":32,"role":27,"phone":20,"phoneExt":20,"email":33},"Jorge Gamonal, Specialist in periodontics","jgamonal@odontologia.uchile.cl",[35],{"facility":36,"status":37,"city":38,"state":39,"zip":20,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Universidad de Chile","RECRUITING","Santiago","Providencia","Chile","CL",{"type":43,"coordinates":44},"Point",[45,46],-70.64827,-33.45694,{"lat":46,"lon":45},[49],{"name":50,"role":27,"phone":51,"phoneExt":20,"email":30},"Melisa Vera Melisa Vera DSD","+56979660028",{"type":24,"investigatorFullName":53,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"MELISA VERA","Principal Investigator, Clinical Periodontist, Universidad de Chile","100584947","effect-of-periodontal-treatment-on-metabolic-control-in-patients-with-type-2-diabetes-mellitus-treated-in-the-cardiovascular-healt-program-100584947",false,"NCT06895980","Effect of Periodontal Treatment on Metabolic Control in Patients with Type-2 Diabetes Mellitus Treated in the Cardiovascular Healt Program","T2D","Inclusion Criteria:\n\n* 1a. Patients enrolled in the PSCV with a diagnosis of type 2 diabetes mellitus and who, in turn, have a glycated hemoglobin ≥ 7% (during the last 6 months).\n* 1b. Patients with a diagnosis of periodontitis (≥ 2 non-adjacent teeth with detectable clinical interproximal attachment loss or, attachment loss ≥ 3mm with depth to probing ≥ 3mm on free faces of ≥ 2 teeth, where the attachment loss was not attributed to non-periodontal causes (Papapanou et al., 2018)).\n\nExclusion Criteria:\n\n* 2a. Patients who have received periodontal treatment during the last year.\n* 2b. Pregnancy\u002Flactation, because they are under treatment under the Explicit Health Guarantee \"Oral and Integral Health of Pregnant Women\".\n* 2c. Therapy with antibiotics and\u002For non-steroidal anti-inflammatory drugs (NSAIDs) in the last 6 months prior to the study.","ALL","18 Years",{"count":65,"type":66},80,"ESTIMATED","INTERVENTIONAL",[69],"NA","The objective of this clinical trial is to evaluate the effect of periodontal treatment on the reduction of glycated hemoglobin levels in adult patients with concurrent type 2 diabetes mellitus and periodontitis.\n\nNon-surgical periodontal treatment and the application of a quality of life survey will be performed and then controls will be carried out for 1 year.",[72,73,74,75],"Periodontitis Chronic Generalized Moderate","Periodontitis","Periodontal Disease","Diabetes Mellitus Type 2",[77,73,78,79,80,81],"HbA1c","Cardiovascular diseases","Diabetes mellitus","type 2 diabetes mellitus","scaling and root planing","2025-03-19",{"date":84,"type":85},"2025-03-26","ACTUAL",{"date":87,"type":85},"2023-08-22",{"date":89,"type":66},"2025-12-31",{"name":5,"class":6},1]